Aziyo Biologics Inc Cl A (ZAYO) | |||
---|---|---|---|
0 (0%) | 04-19 14:12 | ||
Open: | Pre. Close: | ||
High: | Low: | ||
Volume: | 0 | Market Cap: | 0(M) |
Stock Technical Analysis | |
---|---|
Overall: | |
Target: | Six months: 1.76 One year: 2.06 |
Support: | Support1: 1.28 Support2: 1.14 |
Resistance: | Resistance1: 1.51 Resistance2: 1.76 |
Pivot: | 1.28 |
Moving Averages: | MA(5): 1.28 MA(20): 1.29 MA(100): 1.72 MA(250): 2.88 |
MACD: | MACD(12,26): -0.03 Signal(12,26,9): -0.04 |
%K %D: | %K(14,3): 54.95 %D(3): 38.74 |
RSI: | RSI(14): 54.34 |
52-Week: | High: Low: Change(%): -83.2 |
Average Vol(K): | 3-Month: 466 10-Days: 44 |
Prices Prediction (Update @5:00pm) | ||
---|---|---|
If tomorrow: | Open lower | Open higher |
High: | 1.482 - 1.487 | 1.487 - 1.493 |
Low: | 1.356 - 1.362 | 1.362 - 1.369 |
Close: | 1.36 - 1.369 | 1.369 - 1.379 |
Price, MAs and Bollinger Bands |
---|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AZYO ] has closed below upper band by 25.0%. Bollinger Bands are 33.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
Company profile |
---|
Stock chart |
---|
Stock News |
---|
Fri, 19 Apr 2024 Fri, 19 Apr 2024 Fri, 19 Apr 2024 Fri, 19 Apr 2024 Fri, 19 Apr 2024 Fri, 19 Apr 2024 |
Financial Analysis | |
---|---|
Price to Book Value: | Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
Price to Earnings: | Outperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
Discounted cash flow: | Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
Return on Assets: | Neutral |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
Return on Equity: | Neutral |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
Debt to Equity: | Outperform |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Stock Basics & Statistics | |
---|---|
Exchange: | |
Sector: | |
Industry: | |
Shares Out. (M) | 11.94 |
Shares Float (M) | 4.12 |
% Held by Insiders | 2.18 |
% Held by Institutions | 70.44 |
Shares Short (K) | 68 |
Shares Short Prior Month (K) | 100 |
Stock Financials | |
---|---|
EPS | -2.180 |
Book Value (p.s.) | -1.360 |
Profit Margin | -70.13 |
Operating Margin | -49.98 |
Return on Assets (ttm) | -28.8 |
Return on Equity (ttm) | |
Qtrly Rev. Growth | -18.5 |
Gross Profit (p.s.) | 1.610 |
Sales Per Share | 4.054 |
EBITDA (p.s.) | -1.710 |
Qtrly Earnings Growth | |
Operating Cash Flow (M) | -18.32 |
Levered Free Cash Flow (M) | 0.44 |
Stock Valuation | |
---|---|
PE Ratio | -0.63 |
PEG Ratio | |
Price to Book value | -1.01 |
Price to Sales | 0.34 |
Price to Cash Flow | -0.89 |
Stock Dividends | |
---|---|
Dividend | |
Dividend Yield | |
Dividend Growth |